title: [Adverse event and countermeasure with regard to FOLFIRINOX for pancreatic cancer].
authors.forename: Futa
authors.initials: F
authors.lastname: Koga
authors.forename: Hideki
authors.initials: H
authors.lastname: Ueno
authors.forename: Chigusa
authors.initials: C
authors.lastname: Morizane
authors.forename: Shunsuke
authors.initials: S
authors.lastname: Kondo
authors.forename: Yasunari
authors.initials: Y
authors.lastname: Sakamoto
authors.forename: Takuji
authors.initials: T
authors.lastname: Okusaka
mesh_terms: D000970:Antineoplastic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D004334:Drug Administration Schedule; D006801:Humans; D010190:Pancreatic Neoplasms / Q000188:drug therapy*
chemical_list: D000970:Antineoplastic Agents